Search
Close this search box.

Arvinas promotes Taylor to president of R&D, Cacace to CSO

ARTICLE | Management Tracks

Plus: Enterprise hires Renu Gupta as CMO, and chairman retires at TScan

By Gunjan Ohri, Data Content Analyst

June 18, 2024 12:34 AM UTC

Protein degrader company Arvinas Inc. (NASDAQ:ARVN) promoted Ian Taylor to president of R&D, and Angela Cacace to CSO. Taylor joined as VP of pharmacology and translational medicine in 2018, becoming CSO in 2019. Cacace was most recently SVP, neuroscience and platform biology.

Renu Gupta became CMO at Enterprise Therapeutics Ltd., a respiratory disease company. Gupta was CMO at Promedior Inc., a Roche (SIX:ROG; OTCQX:RHHBY) company. The company also added Janet Hammond, the chief development officer of Atea Pharmaceuticals Inc. (NASDAQ:AVIR), to the board…